INTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ:IART) Files An 8-K Entry into a Material Definitive Agreement

On April 20, 2017, Integra LifeSciences Corporation (“ILS”), a
wholly-owned subsidiary of Integra LifeSciences Holdings
Corporation (the “Company”), entered into a lease modification
agreement with Plainsboro Associates relating to its
manufacturing facility located at 105 Morgan Lane, Plainsboro,
New Jersey. Plainsboro Associates is a New Jersey general
partnership. Ocirne, Inc., a subsidiary of Provco Industries
(“Provco”), owns a 50% interest in Plainsboro Associates. Provcos
stockholders are trusts whose beneficiaries include the children
of Dr. Richard Caruso, the Chairman Emeritus and Director
Emeritus of the Company. Dr. Caruso is the President of Provco.

The lease modification agreement provides a twelve-year option
(instead of the prior fifteen-year option) for ILS to extend the
lease term from October 1, 2017 through October 31, 2029. The
rent for the modified term will be $295,515 per year, which is
the same amount the Company would have paid had it exercised the
initial fifteen-year renewal option. In addition, the lease
modification agreement adds two separate five-year renewal
options to extend the lease from November 2029 through October
2039. The first five-year renewal option, from November 2029
through October 2034, will be approximately $357,975 per year,
excluding common area maintenance and other operating expenses.
The second five-year renewal option, from November 2034 through
October 2039, will be at the fair market rental rate of the
premises. After the first five-year renewal option, in the event
the Company exercises the subsequent five-year renewal option,
the landlord will notify the Company as to its opinion as to the
fair market rental rate, which cannot be lower than the rent for
the prior lease term. In making the determination of the fair
market rental rate, no consideration shall be given to the value
of any additions, improvements or special purpose renovations
paid by the Company. If the Company does not agree with the
amount of the fair market rental rate, the parties will have 30
days to negotiate.

Prior to the April 20, 2017 modification agreement, the lease had
an option for ILS to extend the term from November 1, 2017
through October 31, 2039 at a fixed rate of $11.97 per square
foot, or an annual rate of $295,515.36 ($24,626.28 monthly), for
the fifteen-year extension period.

A copy of the lease modification agreement is attached as Exhibit
10.1 to this Current Report on Form 8-K and is incorporated by
reference into this Item.

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits